# MAGIC Cell-5-Combicytokine Trial

> **NCT00501917** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 116 (estimated)

## Conditions studied

- Acute Myocardial Infarction

## Interventions

- **DRUG:** G-CSF with/without darbepoetin, peripheral blood stem cell infusion

## Key facts

- **NCT ID:** NCT00501917
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-03
- **Primary completion:** —
- **Final completion:** 2010-02
- **Target enrollment:** 116 (ESTIMATED)
- **Last updated:** 2007-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00501917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00501917, "MAGIC Cell-5-Combicytokine Trial". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00501917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*